Open an account

Fortrea Holdings

FTRE · NASDAQ

$22.78+$0.36 (+1.61%)TodayMarket closed ·
Prev close $22.42

About FTRE

Fortrea Holdings, Inc. engages in the provision of clinical development and commercialization services. The company is headquartered in Durham, North Carolina and currently employs 14,300 full-time employees. The company went IPO on 2023-06-16. The firm is engaged in providing biopharmaceutical product and medical device development services to pharmaceutical, biotechnology and medical device customers. The firm offers customers flexible delivery models that include full service, functional service provider, and hybrid service structures. The company provides phase I-IV clinical trial management, clinical pharmacology and consulting services. The firm manages its business through a single segment, Clinical Services, that provides services across the clinical pharmacology and clinical development spectrum. The firm has access to all key markets worldwide through a footprint of primary office locations in five countries (the United States, the United Kingdom, China, India and Singapore) with field operations in other jurisdictions worldwide.

Employees
14,300
Headquarters
Durham, North Carolina
Listed
Jun 16, 2023
Sector
Health Care
Industry
Life Sciences Tools & Services
Website
fortrea.com

FTRE key statistics

Market cap
2.17B
Price-earnings ratio
0.00
Dividend yield
—
Average volume
1.64M
Volume
2.38M
Open price
$22.55
High today
$23.55
Low today
$22.31
52 Week high
$23.51
52 Week low
$8.55

Fortrea Holdings (FTRE) at a glance

Fortrea Holdings (FTRE) last traded at $22.78, with a market cap of 2.17B and a price-to-earnings ratio of 0.00.

Today the stock has traded between $22.31 and $23.55. The current price is 2.1% above the day's low and 3.3% below its high.

Volume so far is 2.38M shares, above the average of 1.64M shares a day.

Over the past year Fortrea Holdings has ranged from $8.55 to $23.51, and now sits 95% of the way up that range.

Fortrea Holdings met or beat analyst EPS estimates in 4 of the last 8 quarters. In Q2 FY26 it reported $0.23 per share against an estimate of $0.1841.

The average analyst price target is $21.84, 4.1% below the current price, from 10 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

80%of 10 analyst ratings say Buy
  • Buy80.0%
  • Hold20.0%
  • Sell0.0%
Price target · 13 analystsAvg $21.84
Low
$13.13
Now
$22.78
High
$27.30

FTRE earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 4 of the last 8 quarters, by 147.5% on average.

  1. Q3 FY24: reported $0.23 per share against an estimate of $0.2551
  2. Q4 FY24: reported $0.18 per share against an estimate of $0.3725
  3. Q1 FY25: reported $0.02 per share against an estimate of -$0.075
  4. Q2 FY25: reported $0.19 per share against an estimate of $0.0639
  5. Q3 FY25: reported $0.12 per share against an estimate of $0.1529
  6. Q4 FY25: reported $0.09 per share against an estimate of $0.1634
  7. Q1 FY26: reported $0.16 per share against an estimate of $0.0469
  8. Q2 FY26: reported $0.23 per share against an estimate of $0.1841

FTRE news

  • Vandana Singh

    Fortrea Leverages Early Phase Strengths to Accelerate Market Expansion

  • Press releaseBusiness Wire

    Kaskela Law Firm Announces Investigation of Fortrea Holdings Inc. (FTRE) and Encourages Long-Term FTRE Shareholders with Investment Losses to Contact the Firm

  • Deep Dive Into Fortrea Holdings Stock: Analyst Perspectives (7 Ratings)

  • 12 Health Care Stocks Moving In Friday's Pre-Market Session

  • 12 Health Care Stocks Moving In Wednesday's Pre-Market Session

  • Beyond The Numbers: 7 Analysts Discuss Fortrea Holdings Stock

  • Press releasePRNewswire

    Fortrea Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Fortrea Holdings, Inc. - FTRE

  • Expert Outlook: Fortrea Holdings Through The Eyes Of 6 Analysts

Similar companies

Companies in the same industry as Fortrea Holdings

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.